Amarin Corp PLC (STU:EH3A)
€ 0.494 0.034 (7.39%) Market Cap: 203.20 Mil Enterprise Value: -80.53 Mil PE Ratio: 0 PB Ratio: 0.41 GF Score: 38/100

Amarin Corporation PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 07:00PM GMT
Release Date Price: €5.02 (+4.58%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst for JPMorgan. And we're continuing the 2021 Healthcare Conference today with Amarin. I'm joined by the company's CEO, John Thero.

Before I turn it over to him, I just want to let you know that instead of going across the hall to the breakout room this year, you can ask questions via the portal by clicking that blue Ask a Question button on the webcast, that will send me the questions. I can ask them to management once we move to Q&A after the presentation.

So with that out of the way, let me turn it over to John.

John F. Thero
Amarin Corporation plc - President, CEO & Director

Thanks, Jess, for the invitation and introduction. And thanks to everybody else for joining us here today. I'm excited to be talking about Amarin and what is an upcoming year that we're very encouraged by.

Before I get into reasons for encouragement, I'll start on Slide 2, where I will be making

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot